CCL2 and dry eye syndrome: It was found that the treatment of KCs with IL-33 promoted the migration of MPs (Figure 4(a)) and upregulated the mRNA (Figure 4(b)) and protein (Figure 4(c)) expression levels of ICAM-1 and CCL2.